1. Anderson RC, Harris PN, Lee CC, Maze N, Small RM, Worth HM. The toxicology and pharmacology of tylosin, an antibiotic, and some salts of tylosin. Unpublished report No. VAR.100/c/9 from Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. Submitted to WHO by Elanco Animal Health, Division of Eli Lilly and Company, Indianapolis, IN, USA. 1966.
2. Anderson RC, Worth HM. The acute toxicity of tylosin phosphate. Unpublished study No. 893/TACUTE/AM from Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. Submitted to WHO by Elanco Animal Health, Division of Eli Lilly and Company, Indianapolis, IN, USA. 1961.
3. Augusto J, Smith B, Smith S, Robertson J, Reimschuessel R. Gentamicin-induced nephrotoxicity and nephroneogenesis in Oreochromis nilotica, a tilapian fish. Dis. Aquat. Org. 1996;26(1):49–58.
4. Baggot JD. Some aspects of clinical pharmacokinetics in veterinary medicine: principles of pharmacokinetics. J. Vet. Pharmacol. Ther. 1978;1:111–8.
5. Corcoran JW, Huber ML, Huber FM. Relationship of ribosomal binding and antibacterial properties of tylosin-type antibiotics. J. Antibiot. 1977;30(11):1012–4.